Division of Gastroenterology

Archived Projects: 52

Project Investigator
All Organizations Start date End date
Role of Ceramide in Hepatic Stellate Cell Activation and Liver Fibrosis Jennifer Chen, MD IGHS Faculty Affiliate, Division of Gastroenterology
Identifying the role of opportunistic pathogens including Giardia, Cryptosporidia, Microsporidia and Mycobacterium avium Robert Owen, MD Division of Gastroenterology
Cognitive load theory in the workplace and implications for health professions education: A critical-realist review of studies among diverse professions Division of Gastroenterology
PIANO: Pregnancy in IBD and Neonatal Outcomes: In utero exposure to biologics and increased neonatal infections Division of Gastroenterology
Dysfunctional Immune Development Among Infants Born to Mothers with IBD Division of Gastroenterology
L-Carnitine to Treat Fatigue Associated with Crohn's Disease Division of Gastroenterology
UCSF IBD Fellowship 2013 - 2014 Division of Gastroenterology
HIV Status and Reproductive Aging Affect Liver Fibrosis in HIV/HCV Infected Women Marion Peters, MD IGHS Faculty Affiliate, Division of Gastroenterology, AIDS Research Institute
AIDS Clinical Trials Group Network (ACTG) Marion Peters, MD IGHS Faculty Affiliate, Division of Gastroenterology
Viral Hepatitis C Infection Long-term Cohort Study (V-HICS) Marion Peters, MD IGHS Faculty Affiliate, Division of Gastroenterology, AIDS Research Institute
AIDS Clinical Trials Group (ACTG), TSG Committee Chair funding Marion Peters, MD IGHS Faculty Affiliate, Division of Gastroenterology, AIDS Research Institute
Impact of HIV PMTCT Interventions on HBV Disease in n HIV/HBV Co-infected Women and their Infants Marion Peters, MD Division of Gastroenterology, AIDS Research Institute
Hepatitis C: Studies of Immunity and Pathogenesis Kimberly Page, PhD, MPH Division of Gastroenterology
Resequencing Microarray for Rapid Detection and Antimicrobial Resistance Profiling Division of Gastroenterology
The House Dust Fungal Microbiome - Influences and Effects Division of Gastroenterology
Project 2: Effect of Humanized Anti Pcrv Antibody on Total Bacterial Community Composition of Adult Patients with Ventilator-Associated Pneumonia Division of Gastroenterology
The Human Microbiome in Pediatric Abdominal Pain and Intestinal Inflammation Division of Gastroenterology
Sinusitis in Children and the Nasopharyngeal Microbiome Division of Gastroenterology
Pets and the Infant Microbiome: Effect on Immune Maturation and Atopic Asthma Division of Gastroenterology
Analysis of Urban Aerosols in Major U.S. Cities - Implications for Asthmatic Airways Division of Gastroenterology
Prevention of Emergence of Antibiotic Resistant P. aeruginosa Division of Gastroenterology
Sinus Microbiome Restoration Study Division of Gastroenterology
NKT Cells Recognize and Respond to Microbes at Mucosal Surfaces Division of Gastroenterology
Probiotic Outcomes of Enteric Microbiota Division of Gastroenterology
Role of the Human Microbiome in Inflammatory Bowel Disease amongst Migrant South Asian Populations. Division of Gastroenterology
Patients' HBV Knowledge, Attitudes, Barriers to HBV Care and HBV Treatment Mandana Khalili, MD Division of Gastroenterology
Hepatitis C Therapeutic Registry and Research Network (HCV-TARGET) Mandana Khalili, MD Division of Gastroenterology
Alcohol's impact on immunological and virological profiles in HIV patients Mandana Khalili, MD IGHS Faculty Affiliate, Division of Gastroenterology
Pegylated Interferon Lambda w/wo Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3 Mandana Khalili, MD IGHS Faculty Affiliate, Division of Gastroenterology
Mentoring Multidisciplinary Patient-Oriented Research in Liver Disease Mandana Khalili, MD Division of Gastroenterology
Impact of Hepatitis C on Insulin Sensitivity and Insulin Secretion in Latinos Mandana Khalili, MD Division of Gastroenterology
AI452-020-0092: Phase 3 Blinded Randomized Study of Peginterferon Lambda-1a and Ribavirin Compared to Peginterferon Alfa-2a and Ribavirin, Each Administered with Telaprevir in Subjects with Genotype-1 Chronic Hepatitis C who are Treatment-naïve or Re Mandana Khalili, MD Division of Gastroenterology
BMS-790052 with Peg-Interferon Alfa-2a and Ribavirin in Treatment Naive Subjects with Chronic Hepatitis C Genotype 1 Mandana Khalili, MD Division of Gastroenterology
Mentoring Multidisciplinary Patient-Oriented Research in Viral Hepatitis Mandana Khalili, MD Division of Gastroenterology
BMS-790052 with Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Genotype 1 Infected Subjects Who are Null or Partial Responders to Peginterferon Alfa plus Mandana Khalili, MD Division of Gastroenterology
Hcv-Induced Alterations in Glucose Metabolism Mandana Khalili, MD Division of Gastroenterology
HBV/HIV Co-Infection Research Network Mandana Khalili, MD Division of Gastroenterology
HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network-A Longitudinal, Observational Study Mandana Khalili, MD Division of Gastroenterology
GS-US-367-1172: A Phase 3, Global, Multicenter, Randomized, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination for 8 Weeks Compared to Sofosbuvir/Velpatasvir for 12 Weeks in Direct-Acting Mandana Khalili, MD Division of Gastroenterology
A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults with Compensated Chronic Hepatitis B Mandana Khalili, MD Division of Gastroenterology
Phase III Trial of the Efficacy and Safety of Clevudine Compared With Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients With HBeAg Negative Chronic Hepatitis Due to Hepatitis B Virus Mandana Khalili, MD Division of Gastroenterology
747-303: A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of beticholic Acid in Subjects with Nonalcoholic Steatohepatitis Mandana Khalili, MD IGHS Faculty Affiliate, Division of Gastroenterology
Phase III Trial of the Efficacy and Safety of Clevudine Compared With Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients With HBeAg Negative Chronic Hepatitis Due to Hepatitis B Virus Mandana Khalili, MD Division of Gastroenterology
Mentoring Multidisciplinary Patient-Oriented Research in Viral Hepatitis Mandana Khalili, MD Division of Gastroenterology
Hepatocellular Carcinoma Screening Practices in Hepatitis B (HBV) Infected Asian Americans Mandana Khalili, MD Division of Gastroenterology
GS-US-248-0122: A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead-Sponsored Trials in Subjects with Chronic Hepatitis C Infection Mandana Khalili, MD IGHS Faculty Affiliate, Division of Gastroenterology
A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Adults with Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection Mandana Khalili, MD IGHS Faculty Affiliate, Division of Gastroenterology
A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Switching from Tenofovir Disoproxil Fumarate (TDF) 300 mg QD to Tenofovir Alafenamide (TAF) 25mg QD in Subjects with Chronic Hepatitis B who are Virologically Suppressed Mandana Khalili, MD IGHS Faculty Affiliate, Division of Gastroenterology
Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300mg QD for the Treatment of HBeAg-Negative, Chronic Hepatitis B Mandana Khalili, MD Division of Gastroenterology
A Phase 2, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Ledipasvir/Sofosbuvir in Subjects with Genotype 1, 4, 5 and 6 Chronic HCV Infection Who are on Dialysis for End Stage Renal Disease Mandana Khalili, MD Division of Gastroenterology
Host and Viral Predictors of Prediabetes in at-risk Latinos with Chronic Hepatitis C (HCV) Mandana Khalili, MD Division of Gastroenterology
Screening and Management of Chronic Hepatitis B Virus Infection: A Survey of San Francisco Health Care Providers Mandana Khalili, MD Division of Gastroenterology